Acute Coronary Syndrome News and Research

RSS

Acute Cardiac Care Congress to be held in Istanbul, Turkey

More than 400 scientific abstracts will be presented by international scientists, providing a great source of news stories for journalists.

10 Sep 2012

Long-term cardiac impact of Japan quake revealed

The 2011 earthquake and tsunami that devastated parts of north-eastern Japan led to a significantly increased weekly occurrence of cardiovascular disease in the months after the event, study findings show.

5 Sep 2012

MADONNA: Personalized antiplatelet therapy savior for angioplasty patients?

Personalized antiplatelet treatment may improve cardiac outcomes after percutaneous coronary intervention, researchers suggest.

4 Sep 2012

Long-term cardiac impact of Japan quake revealed

The earthquake and tsunami that devastated parts of eastern Japan in 2011 led to a significantly increased weekly occurrence of cardiovascular disease in the months after the event, study findings show.

29 Aug 2012

AstraZeneca’s ticagrelor receives Class I recommendation from ESC

AstraZeneca today announced that ticagrelor, an oral antiplatelet medicine, received a Class I recommendation from the European Society of Cardiology (ESC) in the revised "Guidelines on the Management of Acute Myocardial Infarction in Patients Presenting with Persistent ST-Segment Elevation (STEMI)" guidelines.

29 Aug 2012

Global platelet reactivity effectively identifies ACS patients at high risk of ischemic events

Global platelet reactivity is more effective than responsiveness to clopidogrel in identifying acute coronary syndrome (ACS) patients at high risk of ischemic events, according to research presented at the ESC Congress today. The results from the RECLOSE 2-ACS study were presented by Dr Rossella Marcucci from Italy.

28 Aug 2012

Personalized antiplatelet treatment leads to better outcomes in patients undergoing PCI

Personalized antiplatelet treatment leads to better outcomes than standard antiplatelet treatment in patients undergoing coronary stent implantation, according to results from the MADONNA study presented at ESC Congress 2012.

28 Aug 2012

Study explores gender-related differences in patients hospitalized for acute heart failure

Women with acute heart failure have similar in-hospital mortality to men but are less treated in the real world, according to results from the global ALARM-HF registry presented today at the ESC Congress 2012. The findings were presented by Dr John T. Parissis from Greece.

27 Aug 2012

Study: Lower use of drug eluting stents in women treated with PCI than men

Drug eluting stents (DES) are used less often in women treated with percutaneous coronary intervention (PCI) for coronary artery disease than men treated with PCI for the same condition, according to research presented today at the ESC Congress 2012.

27 Aug 2012

Prasugrel as safe as clopidogrel in preventing heart attack, stroke and death

The first trial to study patients with acute coronary syndrome who do not undergo coronary stenting or bypass surgery found no significant difference between two anti-clotting drugs - prasugrel and clopidogrel - in preventing the first occurrence of death, heart attack or stroke, according to Duke University Medical Center cardiologists.

27 Aug 2012

CT angiography use ‘unwarranted’ in chest pain patients

Using coronary computed tomography angiography to triage patients with chest pain reduces time to discharge from the emergency department by nearly a third, researchers report in The New England Journal of Medicine.

31 Jul 2012

Paramedics could up their game to meet reperfusion guidelines

Researchers say that Canadian guidelines for reperfusion in ST-segment-elevation myocardial infarction can only be met if electrocardiograms are administered by paramedics.

24 Jul 2012

Training EMS to interpret ECGs can expedite treatment for severe heart attacks

A new program that trains emergency medical service technicians (EMS) to read electrocardiograms so that they can evaluate patients with chest pain, and expedite treatment for the severe heart condition known as ST-segment elevation myocardial infarction (STEMI), a serious form of heart attack, has excellent results and should become the standard of care, according to two studies published in the current issue of the Canadian Journal of Cardiology.

21 Jul 2012

AstraZeneca plans to conduct ticagrelor plus clopidogrel clinical trial for PAD

AstraZeneca today announced plans to conduct the EUCLID study, a global clinical trial involving 11,500 patients with peripheral artery disease (PAD), a condition affecting approximately 27 million people in Europe and North America.

17 Jul 2012

JRD receives FDA priority review designation for XARELTO sNDAs to treat PE, DVT

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental New Drug Applications (sNDAs) filed on May 2, 2012 for XARELTO (rivaroxaban), an oral anticoagulant, seeking new indications to treat patients with deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent recurrent DVT and PE.

9 Jul 2012

Prevalence of significant CAD in patients with chest pain symptoms is lower than expected in Europe

Preliminary findings from the EVINCI study show that the prevalence of "significant" coronary artery disease in patients with chest pain symptoms is lower than expected in Europe. In as much as 75% of this population an accurate non-invasive screening could avoid unnecessary and costly invasive procedures.

28 Jun 2012

Janssen receives FDA complete response letter for XARELTO sNDA

Janssen Research & Development, LLC (Janssen R&D) announced today the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding a supplemental New Drug Application (sNDA) for XARELTO (rivaroxaban) for the reduction of the risk of secondary cardiovascular events in patients with acute coronary syndrome (ACS).

22 Jun 2012

One in eight people with heart attack experience significant symptoms of PTSD

One in eight people who suffer a heart attack or other acute coronary event experience clinically significant symptoms of post-traumatic stress disorder (PTSD), according to a meta-analysis of 24 studies led by Columbia University Medical Center researchers.

21 Jun 2012

Sustained ventricular arrhythmias in NSTE ACS rare but high-risk

Sustained ventricular fibrillation or tachycardia in patients admitted with non-ST-segment elevation acute coronary syndrome are uncommon but worsen patients’ prognosis markedly if they do develop, researchers report.

19 Jun 2012

Miracor receives three new U.S. patents for novel PICSO system to treat STEMI

Miracor Medical Systems announced today that it has been granted three new U.S. patents covering a unique dual balloon method and the new "Wien Algorithm" of its novel PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) system that ensures a stable and repeatable PICSO treatment designed to improve myocardial perfusion following primary PCI (Percutaneous Coronary Intervention, or angioplasty).

31 May 2012